Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Zawartość zarchiwizowana w dniu 2024-06-18

From sea-bed to test-bed: harvesting the potential of marine microbes for industrial biotechnology

Cel

SeaBioTech is a 48-month project designed and driven by SMEs to create innovative marine biodiscovery pipelines as a means to convert the potential of marine biotechnology into novel industrial products for the pharmaceutical (human and aquaculture), cosmetic, functional food and industrial chemistry sectors. SeaBioTech will reduce barriers to successful industrial exploitation of marine biodiversity for companies more accustomed to ‘terrestrial’ biotechnology. SeaBioTech directly addresses five key challenges to remove bottlenecks in the marine biodiscovery pipeline, leading to (1) improvements in the quality of marine resources available for biotechnological exploitation, (2) improvement in technical aspects of the biodiscovery pipeline to shorten time to market, and (3) developing sustainable modes of supply of raw materials for industry. The two last challenges centre on enabling activities to enhance the marine biodiscovery process: first, clarification of legal aspects to facilitate access to marine resources, their sustainable use, and their secure exploitation; second, to create an improved framework for access to marine biotechnology data and research materials. To achieve its goals, SeaBioTech brings together complementary and world-leading experts, integrating biology, genomics, natural product chemistry, bioactivity testing, industrial bioprocessing, legal aspects, market analysis and knowledge exchange. The expertise assembled within the consortium reflects the industry-defined needs, from the SME partners’ initial definition of market and product opportunities to their ultimate proof-of-concept demonstration activities. SeaBioTech will have significant impact on research and technology, on innovation, on European competitiveness and on economic growth. It will provide a model to accelerate the development of European biotechnology into a world leading position.

Zaproszenie do składania wniosków

FP7-KBBE-2012-6-singlestage
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

UNIVERSITY OF STRATHCLYDE
Wkład UE
€ 1 803 588,00
Adres
Richmond Street 16
G1 1XQ Glasgow
Zjednoczone Królestwo

Zobacz na mapie

Region
Scotland West Central Scotland Glasgow City
Rodzaj działalności
Higher or Secondary Education Establishments
Kontakt administracyjny
Martin Gregory (Mr.)
Linki
Koszt całkowity
Brak danych

Uczestnicy (15)